Herbies Headshop

Medical Cannabis News

Three Studies Shed New Light on the Effectiveness of Cannabis in Epilepsy

West Hartford, Conn., October 14, 2014 – In advance of the American Epilepsy Society’s (AES) Annual Meeting in December, the organization has offered highlights of groundbreaking research being studied at a number of institutions regarding the effectiveness of cannibidiol (CBD) and its derivatives as a viable treatment for people with epilepsy.

The first of three studies (Abstract#2016808) will be presented in full at the Annual Meeting is from Colorado, where much of the nation’s attention has been captured by issues surrounding cannabis.  The physicians and researchers at Children’s Hospital Colorado and the University of Colorado have a unique perspective on CBD given the large number of cases they have treated. In addition to the many children already in their care, these professionals are now caring for many of the patients who have ventured to Colorado in search of cannabis treatment.

Cannabis Use in Teenagers Has 'No Relationship' with IQ or Exam Results

There is no connection between occasional adolescent cannabis use in adolescents and IQ or exam results, a large UK-based study has found.

Although the research shows moderate cannabis use does not lead to poorer education and intellectual performance, heavy marijuana use is associated with slightly poorer exam results at the age of 16.

GW Pharmaceuticals Epidiolex® Orphan Designation from European Medicines Agency and Fast Track Designation

Cannabis Based Drug Epidiolex® Receives Orphan Designation from European Medicines Agency and Fast Track designation from the FDA for the Treatment of Dravet Syndrome

London, UK; 22 October 2014: GW Pharmaceuticals plc announced that the European Medicines Agency (EMA) has granted orphan designation to GW’s investigational product Epidiolex® (cannabidiol or CBD) in the treatment of Dravet syndrome, a rare and catastrophic treatment-resistant form of childhood epilepsy.

GW Pharmaceuticals Announces New Physician Reports of Epidiolex® Treatment Effect in Children and Young Adults with Treatment-Resistant Epilepsy

14 October 2014: GW Pharmaceuticals plc announced new physician reports of efficacy and safety associated with the Epidiolex® “expanded access” studies.

Physician reports of efficacy and safety data have been made available on 58 children and young adults with treatment-resistant epilepsy who have been treated with GW’s investigational cannabidiol (CBD) product candidate, Epidiolex, for a period of at least 12 weeks. This includes 27 patients on whom data was reported in June 2014 and an additional 31 patients on whom data has recently been made available to the Company. In addition, of the 58 total patients, 40 patients have been treated for at least 16 weeks and data has been available for this time period also. These data are from three hospital sites in the United States and were generated under expanded access Investigational New Drug applications (INDs) authorized by the U.S. Food and Drug Administration (FDA).  In addition, physician reports of safety data were made available on 151 patients (58 patients with 12 weeks treatment effect data plus 93 additional patients for whom 12 week treatment effect data is not yet available).

GW Pharmaceuticals Announces Preliminary Results of Phase 2a Ulcerative Colitis Trial

14 October 2014: The Phase 2a pilot trial was a 10-week randomized, double-blind, placebo controlled study of GWP42003 extract, which features Cannabidiol (CBD) as the primary cannabinoid and which also contains Tetrahyrdocannabinol (THC) and other cannabinoid and non-cannabinoid components. The trial included 60 adult patients with ulcerative colitis who had not been able to gain remission from the condition despite first line treatment with salicylates, and in some cases immunosuppressive therapy.

cannabis seeds

autoflowering cannabis seeds

funny weed memes

Want to grow your own?

If you are looking for good quality seed to grow your own medicine at home, then check out those guys from Royal Queen Seeds.  With more than 2 decades of experience they ship their medical cannabis seeds world wide and guarantee top quality for the best price. Award winners shipped stealth!  What more do you need?